Senior insider sale
Chief Financial Officer at SOLENO THERAPEUTICS INC — senior position signals high conviction
$4.99M
100.37K shares
What this filing means
MACKANESS JAMES H plans to sell 100.37K shares of SOLENO THERAPEUTICS INC valued at approximately $4.99M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/27/2025ACC: 0001415889-25-009079
Officer· Chief Financial Officer
Since Nov 2019
100.37K
Shares to sell
$4.99M
Approx. market value
92.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Stock option exercises
Cash
3/27/2025
70KVesting of Restricted Stock Units - See Remarks
Equity Compensation
3/26/2025
22.50KTotal acquired92.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/27/2025 | Stock option exercises Cash | 70K | — |
3/26/2025 | Vesting of Restricted Stock Units - See Remarks Equity Compensation | 22.50K | — |
| Total | 92.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.79K
Market value
$175.1K
1/3/2025
—Completed
Units to sell
4.08K
Market value
$185.4K
1/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
92.50K
Market value
$4.63M
3/27/2025
Total
Units
100.37K
Value
$4.99M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/3/2025 | 3.79K | $175.1K | — | Completed |
1/2/2025 | 4.08K | $185.4K | — | Completed |
| Planned — Approximate Date | ||||
3/27/2025 | 92.50K | $4.63M | NASDAQ | Planned |
| Total | 100.37K | $4.99M | ||